Oric Pharmaceuticals Inc.
Organization details
- Legal name
- Oric Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ORIC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001796280
- EIN
- 47-1787157
Board of directors
-
Angie You · DirectorSince 2023
-
Jacob Chacko · Director · PRESIDENT AND CEOSince 2023
-
Lori Anne Kunkel · DirectorSince 2023
-
Mardi Dier · DirectorSince 2023
-
Richard A. Heyman · DirectorSince 2023
-
Steven L. Hoerter · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.4%
-
99.6%
Board connections
6 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
Enliven Therapeutics Inc. Same sectorvia Lori Anne Kunkel and Richard A. Heyman
-
4D Molecular Therapeutics Inc. Same sectorvia Jacob Chacko
-
Attovia Therapeutics Inc. Same sectorvia Angie You
-
C4 Therapeutics Inc. Same sectorvia Steven L. Hoerter
-
MBX Biosciences Inc. Same sectorvia Steven L. Hoerter
-
Nurix Therapeutics Inc. Same sectorvia Lori Anne Kunkel
-
PMV Pharmaceuticals Inc. Same sectorvia Richard A. Heyman
-
Prelude Therapeutics Incorporated Same sectorvia Mardi Dier
-
Yarrow Bioscience Inc. Same sectorvia Steven L. Hoerter
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,960,049
- 16 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 20, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +14,000 | $4.36 | $61,040 |
| Oct 20, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −14,000 | $13.53 | $189,391 |
| Oct 1, 2026 | Richard A. Heyman Director | Option exercise | +3,500 | $1.60 | $5,600 |
| Oct 1, 2026 | Richard A. Heyman Director | Open-market sale | −3,500 | $12.91 | $45,199 |
| Oct 1, 2026 | Richard A. Heyman Director | Open-market sale | −3,200 | $12.91 | $41,325 |
| Sep 28, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +13,400 | $4.36 | $58,424 |
| Sep 28, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −13,400 | $13.53 | $181,302 |
| Sep 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +600 | $4.36 | $2,616 |
| Sep 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −100 | $13.50 | $1,350 |
| Sep 24, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −500 | $13.51 | $6,755 |
| Aug 26, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +52,000 | $4.36 | $226,720 |
| Aug 26, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Option exercise | +25,000 | $6.00 | $150,000 |
| Aug 26, 2026 | Piscitelli Dominic Officer (Chief Financial Officer) | Open-market sale | −77,000 | $13.69 | $1,054,130 |
| Jul 24, 2026 | Richard A. Heyman Director | Option exercise | +3,500 | $1.60 | $5,600 |
| Jul 24, 2026 | Richard A. Heyman Director | Open-market sale | −7,000 | $12.02 | $84,140 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Oric Pharmaceuticals Inc.
Who is the CEO of Oric Pharmaceuticals Inc.?
Jacob Chacko is Oric Pharmaceuticals Inc.'s President and CEO.
How many directors are on Oric Pharmaceuticals Inc.'s board?
Oric Pharmaceuticals Inc.'s board has 6 directors: Angie You, Jacob Chacko, Lori Anne Kunkel, Mardi Dier, Richard A. Heyman and Steven L. Hoerter.
Are Oric Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Oric Pharmaceuticals Inc. insiders made no open-market purchases and sold $3.0 million of shares in 16 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="oric-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.